Adenosine, a metabolite of ATP, serves a number of important physiological
roles in the body. These actions contribute to sedation, bradycardia, vasor
elaxation, inhibition of lipolysis and regulation of the immune system and
are mediated, in part, through activation of three distinct adenosine recep
tor (AR) subtypes. To date, four receptor types have been cloned: A(1), A(2
A), A(2B) and A(3). It is becoming increasing clear that adenosine contribu
tes significantly to cytoprotection, a function mediated principally by the
A(1)AR and A(3)AR, In this review, we survey the literature on the role of
adenosine and the mechanisms underlying cytoprotection and ischemic precon
ditioning, a process characterized by cytoprotection derived from repeated
brief ischemic challenges. An important recent observation is that the expr
ession of several AR subtypes could be regulated by oxidative stress to pro
vide a greater cytoprotective role. Thus, like other proteins known to be r
egulated during ischemia, the A(1)AR and A(3)AR can be considered as being
inducible receptors.